Gene · 406962
Papers2,086
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,086
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA SNHG6 role in clinicopathological parameters in cancers. | Eur J Med Res | 2023 | 37735423 | PubTator, text mining | PubMed |
| Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs. | J Transl Med | 2023 | 37715207 | PubTator, text mining | PubMed |
| Unlocking the potential of microRNAs: machine learning identifies key biomarkers for myocardial infarction diagnosis. | Cardiovasc Diabetol | 2023 | 37697288 | PubTator, text mining | PubMed |
| Standardized Polyalthia longifolia leaf extract induces the apoptotic HeLa cells death via microRNA regulation: identification, validation, and therapeutic potential. | Front Pharmacol | 2023 | 37693900 | PubTator, text mining | PubMed |
| Common miRNAs of Osteoporosis and Fibromyalgia: A Review. | Int J Mol Sci | 2023 | 37686318 | PubTator, text mining | PubMed |
| Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities. | Int J Mol Sci | 2023 | 37685951 | PubTator, text mining | PubMed |
| Current Advances in Cellular Approaches for Pathophysiology and Treatment of Polycystic Ovary Syndrome. | Cells | 2023 | 37681921 | PubTator, text mining | PubMed |
| FOXP2 confers oncogenic effects in prostate cancer. | Elife | 2023 | 37668356 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review. | J Reprod Infertil | 2023 | 37663424 | PubTator, text mining | PubMed |
| Validation of reference gene stability for miRNA quantification by reverse transcription quantitative PCR in the peripheral blood of patients with COVID-19 critical illness. | PLoS One | 2023 | 37643172 | PubTator, text mining | PubMed |
| Regulatory miRNAs and lncRNAs in Skin Cancer: A Narrative Review. | Life (Basel) | 2023 | 37629553 | PubTator, text mining | PubMed |
| 3D Culture and Interferon-γ Priming Modulates Characteristics of Mesenchymal Stromal/Stem Cells by Modifying the Expression of Both Intracellular and Exosomal microRNAs. | Biology (Basel) | 2023 | 37626949 | PubTator, text mining | PubMed |
| Role of Fork-Head Box Genes in Breast Cancer: From Drug Resistance to Therapeutic Targets. | Biomedicines | 2023 | 37626655 | PubTator, text mining | PubMed |
| The Circular RNA circFGFR4 Facilitates Resistance to Anti-PD-1 of Triple-Negative Breast Cancer by Targeting the miR-185-5p/CXCR4 Axis. | Cancer Manag Res | 2023 | 37601820 | PubTator, text mining | PubMed |
| EXPRESSION LEVELS OF FOXO-1, P27KIP1, MIR-27, MIR-186 AND AKT1/AKT-P PROTEINS IN WOMEN WITH ENDOMETRIAL CANCER AND HYPERPLASIA: IMPLICATIONS FOR THE HUMAN REPRODUCTIVE SYSTEM. | Acta Endocrinol (Buchar) | 2023 | 37601705 | PubTator, text mining | PubMed |
| Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma. | Transl Lung Cancer Res | 2023 | 37577299 | PubTator, text mining | PubMed |
| Connection between Radiation-Regulating Functions of Natural Products and miRNAs Targeting Radiomodulation and Exosome Biogenesis. | Int J Mol Sci | 2023 | 37569824 | PubTator, text mining | PubMed |
| CircUSP48 promotes malignant behavior by regulating CYR61 via miR-365 in osteosarcoma. | Funct Integr Genomics | 2023 | 37553503 | PubTator, text mining | PubMed |
| Novel insights regarding the role of noncoding RNAs in diabetes. | World J Diabetes | 2023 | 37547582 | PubTator, text mining | PubMed |
| Extracellular circulating miRNAs as potential non-invasive biomarkers in non-small cell lung cancer patients. | Front Oncol | 2023 | 37546401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406962/papers?page=7